Cointime

Verily

company

About

Verily develops tools and devices to collect and analyze health data to research and manage diseases.

Highlights

Total Funding Amount
$3.50B
Funding Rounds
5
Investors
6
Investments
17
Lead Investments
2
Exits
4

Details

Last Funding Type
Private Equity（PE）
Last Funding Money Raised
$1B
Industries
Analytics,Enterprise Software,Health Care,Information Technology
Founded date
Jan 1, 2015
Number Of Employee
1001 - 5000
Operating Status
Active
Legal Name
Verily Life Sciences LLC
Also Known As
Google Life Sciences

Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies and start companies.

The company was founded in 2015 and is based in San Francisco, California, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$3.50B
Verily has raised a total of $3.50B in funding over 2 rounds. Their latest funding was raised on Sep 28, 2022 from a Secondary Market round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 28, 2022 Secondary Market — 1 Swiss Re Corporate Solutions — Detail
Sep 9, 2022 Corporate Round $1B 1 Google — Detail
Dec 17, 2020 Series Unknown $700M 4 — — Detail
Jan 3, 2019 Private Equity（PE） $1B 1 Silver Lake — Detail
Jan 26, 2017 Private Equity（PE） $800M 1 Temasek Holdings — Detail

Investments

Number of Investments
Number of Lead Investments
17
2
Verily has made 17 investments. Their most recent investment was on May 1, 2022, when The Public Health Company raised $35M.
Date Company Name
Round Money Raised Industry Lead Investor
May 1, 2022 The Public Health Company
Series A $35M Biotechnology —
Feb 7, 2022 Syllable
Series C $40M Artificial Intelligence —
Dec 17, 2021 EQRx
Post-IPO Equity $1.20B Biotechnology —
Oct 14, 2021 Culture Biosciences
Series B $80M Biotechnology —
May 11, 2021 Marvin
Seed $6.20M Health Care Yes
Show More

Investors

Number of Lead Investors
Number of Investors
4
6
Verily is funded by 6 investors. Swiss Re Corporate Solutions and Google are the most recent investors.
Investor Name Lead Investor Funding Round
Swiss Re Corporate Solutions Yes Secondary Market
Google Yes Corporate Round
Silver Lake — Series Unknown
Alphabet — Series Unknown
Ontario Teachers' Pension Plan — Series Unknown
Temasek Holdings — Series Unknown

Employee Profiles

Number of Employee Profiles
35
Verily has 35 current employee profiles, including Employee Yukkee Poh
Yukkee Poh
Employee
Kathryn Twyman
Executive
Lynda Moyer
Employee
Duncan Welstead
Executive
Show More

Exits

Verily has had 4 exits. Verily most notable exits include EQRx ,   Ciitizen

Date Company Name Exit Type Industry
Dec 17, 2021 EQRx IPO Biotechnology Detail
Sep 7, 2021 Ciitizen M&A Health Care Detail
Mar 3, 2021 Oscar Health IPO Health Care Detail
May 8, 2019 Cortexyme IPO Biotechnology Detail

Acquisition

Verily has acquired 2 organizations. Their most recent acquisition was SignalPath on Aug 17, 2021. They acquired SignalPath for 0.

Date Company Name
Industry Acquisition Type Price
Aug 17, 2021 SignalPath
Information Technology acquisition — Detail
Sep 29, 2022 Granular
Financial Services acquisition — Detail
Cointime
İçerikler
Şirket.